Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects.

The multiple-dose pharmacokinetics of ritonavir were investigated in four groups of human immunodeficiency virus-positive male subjects (with 16 subjects per group) under nonfasting conditions; a 3:1 ritonavir:placebo ratio was used. Ritonavir was given at 200 (group I), 300 (group II), 400 (group I...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hsu, A, Granneman, G R, Witt, G, Locke, C, Denissen, J, Molla, A, Valdes, J, Smith, J, Erdman, K, Lyons, N, Niu, P, Decourt, J P, Fourtillan, J B, Girault, J, Leonard, J M
Format: Artigo
Idioma:Inglês
Publicat: 1997
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC163822/
https://ncbi.nlm.nih.gov/pubmed/9145841
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars